Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Am J Chin Med ; 48(6): 1369-1383, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-32933311

RESUMO

Age-related myocardial dysfunction is a very large healthcare burden. Here, we aimed to investigate whether ginsenoside Rb1 (Rb1) improves age-related myocardial dysfunction and to identify the relevant molecular mechanism. Young mice and aged mice were injected with Rb1 or vehicle for 3 months. Then, their cardiac function was inspected by transthoracic echocardiography. Serum and myocardium tissue were collected from all mice for histological or molecular expression analyses, including aging-related proteins, markers relevant to fibrosis and inflammation, and markers indicating the activation of the nuclear factor-kappa B (NF-[Formula: see text]B) pathway. Compared with the control condition, Rb1 treatment significantly increased the ejection fraction percentage and significantly decreased the internal diameter and volume of the left ventricle at the end-systolic and end-diastolic phases in aged mice. Rb1 treatment reduced collagen deposition and collagen I, collagen III, and transforming growth factor-[Formula: see text]1 protein expression levels in aged hearts. Rb1 also decreased the aging-induced myocardial inflammatory response, as measured by serum or myocardial interleukin-6 and tumor necrosis factor-[Formula: see text] levels. Furthermore, Rb1 treatment in aged mice increased cytoplasmic NF-[Formula: see text]B but decreased nuclear NF-[Formula: see text]B, which indicated the suppression of the NF-[Formula: see text]B signaling pathway by regulating the translocation of NF-[Formula: see text]B. Rb1 could alleviate aging-related myocardial dysfunction by suppressing fibrosis and inflammation, which is potentially associated with regulation of the NF-[Formula: see text]B signaling pathway.


Assuntos
Envelhecimento , Ginsenosídeos/farmacologia , Ginsenosídeos/uso terapêutico , Insuficiência Cardíaca/tratamento farmacológico , NF-kappa B/genética , NF-kappa B/metabolismo , Fitoterapia , Animais , Anti-Inflamatórios , Colágeno/metabolismo , Feminino , Expressão Gênica/efeitos dos fármacos , Insuficiência Cardíaca/etiologia , Insuficiência Cardíaca/genética , Insuficiência Cardíaca/metabolismo , Camundongos Endogâmicos C57BL , Transdução de Sinais , Volume Sistólico/efeitos dos fármacos
2.
J Cardiovasc Pharmacol ; 59(3): 222-30, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-22030897

RESUMO

OBJECTIVE: Senescence of endothelial cells has been implicated in endothelial dysfunction and atherogenesis. This study investigated the effects of Rb1, a major ginsenoside in ginseng, on H2O2-induced senescence in primary human umbilical vein endothelial cells (HUVECs). METHODS AND RESULTS: Real-time PCR and Western blot were used to detect the mRNA and protein expression, respectively. H2O2 (40∼100 µmol/L) effectively increased SA-ß-gal activity and PAI-1 mRNA levels, two important senescence related biomarkers, in HUVECs, which were dramatically inhibited by Rb1 pre-incubation. Furthermore, Rb1 administration reversed the H2O2-decreased protein and mRNA levels of eNOS and its phosphorylation at Ser-1177, and the increased eNOS phosphorylation at Thr-495. As a result, Rb1 pretreatment restored the NO generation, as assayed by nitrate reductase method. However, pretreatment with L-NAME, a NOS inhibitor, abolished all the inhibitory effects of Rb1 on senescence. Importantly, Rb1 modulated the H2O2-altered caveolin-1 and pAkt, two most important regulators of eNOS expression and activity, in HUVECs. CONCLUSIONS: We showed that Rb1 effectively protects HUVECs from senescence through eNOS modulation.


Assuntos
Senescência Celular/efeitos dos fármacos , Ginsenosídeos/farmacologia , Óxido Nítrico Sintase Tipo III/metabolismo , Óxido Nítrico/metabolismo , Western Blotting , Relação Dose-Resposta a Droga , Regulação da Expressão Gênica/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Humanos , Peróxido de Hidrogênio/administração & dosagem , Peróxido de Hidrogênio/toxicidade , Óxido Nítrico Sintase Tipo III/genética , Fosforilação/efeitos dos fármacos , Inibidor 1 de Ativador de Plasminogênio/genética , Reação em Cadeia da Polimerase , RNA Mensageiro/metabolismo , beta-Galactosidase/metabolismo
3.
Biol Pharm Bull ; 34(7): 1072-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21720015

RESUMO

Senescence of endothelial cells has been proposed to play an important role in endothelial dysfunction and atherogenesis. In the present study we aimed to investigate whether ginsenoside Rb1, a major constituent of ginseng, protects endothelial cells from H(2)O(2)-induced endothelial senescence. While H(2)O(2) induced premature senescent-like phenotype of human umbilical vein endothelial cells (HUVECs), as judged by increased senescence-associated ß-galactosidase (SA-ß-gal) activity, enlarged, flattened cell morphology and sustained growth arrest, our results demonstrated that Rb1 protected endothelial cells from oxidative stress induced senescence. Mechanistically, we found that Rb1 could markedly increase intracellular superoxide dismutase (Cu/Zn SOD/SOD1) activity and decrease the malondialdehyde (MDA) level in H(2)O(2)-treated HUVECs, and suppress the generation of intracellular reactive oxygen species (ROS). Consistent with these findings, Rb1 could effectively restore the protein expression of Cu/Zn SOD, which was down-regulated in H(2)O(2) treated cells. Taken together, our data demonstrate that Rb1 exhibits antioxidant effects and antagonizes H(2)O(2)-induced cellular senescence.


Assuntos
Senescência Celular/efeitos dos fármacos , Endotélio Vascular/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Proteína do Retinoblastoma/fisiologia , Sequência de Bases , Células Cultivadas , Primers do DNA , Endotélio Vascular/citologia , Endotélio Vascular/enzimologia , Endotélio Vascular/metabolismo , Sequestradores de Radicais Livres , Humanos , Malondialdeído/metabolismo , Oxirredução , Reação em Cadeia da Polimerase em Tempo Real , Superóxido Dismutase/metabolismo
4.
Nan Fang Yi Ke Da Xue Xue Bao ; 28(9): 1703-6, 2008 Aug.
Artigo em Chinês | MEDLINE | ID: mdl-18819903

RESUMO

OBJECTIVE: To investigate the effect of the sera of rabbits fed with Tongxinluo on the expression and secretion of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in U937 monocyte-derived macrophages. METHODS: Atherosclerosis was induced in rabbits by high-cholesterol feeding, and the serum was obtained from the rabbits after administration of the aqueous solution of Tongxinluo or simvastatin by gavage. U937 monocyte-derived macrophages were incubated with the sera at different concentrations for 24 hours, and the changes in MMP-9 and TIMP-1 gene expression and secretion were detected by RT-PCR and enzyme-linked immunosorbent assay, respectively. RESULTS: The serum of rabbits fed with Tongxinluo concentration-dependently inhibited the expression and secretion of MMP-9 in U937 macrophages, but did not affect TIMP-1 expression or secretion. CONCLUSION: Tongxinluo may stabilize the atherosclerotic plaques by inhibiting the expression and secretion of MMP-9.


Assuntos
Medicamentos de Ervas Chinesas/farmacologia , Macrófagos/efeitos dos fármacos , Metaloproteinase 9 da Matriz/biossíntese , Inibidor Tecidual de Metaloproteinase-1/biossíntese , Animais , Aterosclerose/sangue , Aterosclerose/etiologia , Colesterol na Dieta/administração & dosagem , Ensaio de Imunoadsorção Enzimática , Humanos , Macrófagos/metabolismo , Masculino , Metaloproteinase 9 da Matriz/genética , RNA Mensageiro/biossíntese , RNA Mensageiro/genética , Coelhos , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Soro , Inibidor Tecidual de Metaloproteinase-1/genética , Células U937
5.
Di Yi Jun Yi Da Xue Xue Bao ; 24(2): 204-6, 2004 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-14965829

RESUMO

OBJECTIVE: To study the intima-media thickness (IMT), plaque score in the carotid artery of patients with acute coronary syndrome (ACS) and the relationship between high-sensitivity C-reactive protein (hs-CRP) and the plaque score. METHODS: Using high-resolution ultrasonic instrument, IMT and the plaque score in the carotid artery were detected in 30 patients with ACS, 29 patients with stable angina pectoris SAP and 17 control subjects, in addition to the measurement of hs-CRP. RESULTS: Compared with SAP and control groups, IMT, total plaque score, soft and hard plaque scores in the carotid artery in ACS group were significantly increased (P<0.001). Hs-CRP (4.336+/-1.334 mg/L) in ACS group were significantly increased (P<0.001) as compared with that in SAP group (2.205+/-0.458 mg/L) and control group (1.625+/-0.434 mg/L). Hs-CRP had positive relationship with the IMT, whole plaque score, soft and hard plaque scores in the carotid artery, respectively. CONCLUSION: IMT, total plaque score, soft and hard plaque scores in the carotid artery in ACS group are significantly increased, and hs-CRP is positively related to IMT, total plaque score, soft and hard plaque scores in the carotid artery, respectively.


Assuntos
Estenose das Carótidas/diagnóstico , Adulto , Idoso , Proteína C-Reativa/análise , Estenose das Carótidas/patologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Túnica Média/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...